Anthropic launched Cowork, bringing the autonomous capabilities of its developer-focused Claude Code tool to non-technical ...
Jacob Fatu showed up and went right after the WWE champion. They fought at ringside as an amused Viper watched from the ring.
No Kawhi Leonard, no problem for the Los Angeles Clippers. At least for one night.
AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...
Bored Panda on MSN
34 stories about exceptionally intelligent people
People tend to flex their intelligence for a number of reasons, including deep-seated insecurities, asserting their identity, ...
Here are five players who played for the Ravens that might interest the Giants in free agency this offseason: Center Tyler Linderbaum, Tight end Isaiah Likely, Offensive tackle Joseph Noteboom, ...
India Today on MSN
The new frontiers of AI
With the Fifth Industrial Revolution upon us, India is building the full AI stack. It will make AI work at scale but rooted ...
Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...
Philomath High ranks No. 12 statewide, Mayor McMorran addresses grocery store obstacles through zoning updates, and beavers prompt innovative fence solution at Bald Hill Farm.
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...
Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results